Bartl S., Queslati A., Southwell A., Siddu A., Parth M., Maxan D.L., A., Salhat N., Burkert M., Mairhofer A., Friedrich T., Pankevych H., Balazs K., Staffler G., Hayden M., Cicchetti F. and Smrzka O.; “Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington’s disease,” Neurobiol. Dis., vol. 141, Jul. 2020, doi: 10.1016/J.NBD.2020.104943.

https://www.sciencedirect.com/science/article/pii/S0969996120302187

Bartl S., Xie Y., Potluri N., Kesineni R., Hencak K., Cengio L.D, Balazs K., Oueslati A., Parth M., Salhat N., Siddu A., Smrzka O., Cicchetti F., Straffler G., Hayden M.R. and Southwell A.L.; “Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease,” Neurobiol. Dis., vol. 190, p. 106376, Jan. 2024, doi: 10.1016/J.NBD.2023.106376.

https://www.sciencedirect.com/science/article/pii/S0969996123003923